{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T08:57:28Z","timestamp":1765961848831,"version":"3.37.3"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014869","name":"Army Medical University Xinqiao Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014869","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012669","name":"Natural Science Foundation Project of Chongqing","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012669","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017501","name":"Science Health Joint Medical Scientific Research Project of Chongqing","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017501","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ejphar.2024.177058","type":"journal-article","created":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T06:17:03Z","timestamp":1728886623000},"page":"177058","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Low-dose treatment with Epirubicin, a novel histone deacetylase 1 inhibitor, exerts anti-leukemic effects by inducing ferroptosis"],"prefix":"10.1016","volume":"985","author":[{"given":"Guancui","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shijie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiarun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peijie","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaolong","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2024.177058_bib1","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28693","article-title":"Drug repurposing for viral cancers: a paradigm of machine learning, deep learning, and virtual screening-based approaches","volume":"95","author":"Ahmed","year":"2023","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.ejphar.2024.177058_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/cells12081128","article-title":"Molecular mechanisms of ferroptosis and updates of ferroptosis studies in cancers and leukemia","volume":"12","author":"Akiyama","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.ejphar.2024.177058_bib3","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/ejh.13183","article-title":"Ferritin heavy\/light chain (FTH1\/FTL) expression, serum ferritin levels, and their functional as well as prognostic roles in acute myeloid leukemia","volume":"102","author":"Bertoli","year":"2019","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.ejphar.2024.177058_bib4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13045-023-01424-6","article-title":"Recent advances in targeted therapies in acute myeloid leukemia","volume":"16","author":"Bhansali","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.ejphar.2024.177058_bib5","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3324\/haematol.2020.259531","article-title":"APR-246 induces early cell death by ferroptosis in acute myeloid leukemia","volume":"107","author":"Birsen","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.ejphar.2024.177058_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108190","article-title":"HDACs and the epigenetic plasticity of cancer cells: target the complexity","volume":"238","author":"Brancolini","year":"2022","journal-title":"Pharmacology & therapeutics"},{"key":"10.1016\/j.ejphar.2024.177058_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.590226","article-title":"Iron metabolism in ferroptosis","volume":"8","author":"Chen","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ejphar.2024.177058_bib8","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1182\/blood-2014-10-605238","article-title":"Histone deacetylase inhibition regulates inflammation and enhances Tregs after allogeneic hematopoietic cell transplantation in humans","volume":"125","author":"Choi","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2024.177058_bib9","doi-asserted-by":"crossref","first-page":"4534","DOI":"10.1021\/bm501338r","article-title":"Vorinostat-polymer conjugate nanoparticles for Acid-responsive delivery and passive tumor targeting","volume":"15","author":"Denis","year":"2014","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ejphar.2024.177058_bib10","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2024.177058_bib11","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.freeradbiomed.2018.12.011","article-title":"DHA inhibits proliferation and induces ferroptosis of leukemia cells through autophagy dependent degradation of ferritin","volume":"131","author":"Du","year":"2019","journal-title":"Free radical biology & medicine"},{"key":"10.1016\/j.ejphar.2024.177058_bib12","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1517\/13543784.16.7.1111","article-title":"Vorinostat: a new oral histone deacetylase inhibitor approved for cutaneous T-cell lymphoma","volume":"16","author":"Duvic","year":"2007","journal-title":"Expet Opin. Invest. Drugs"},{"key":"10.1016\/j.ejphar.2024.177058_bib13","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1016\/j.celrep.2020.02.049","article-title":"Transferrin receptor is a specific ferroptosis marker","volume":"30","author":"Feng","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.ejphar.2024.177058_bib14","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.cmet.2005.02.005","article-title":"Cellular iron: ferroportin is the only way out","volume":"1","author":"Ganz","year":"2005","journal-title":"Cell Metabol."},{"key":"10.1016\/j.ejphar.2024.177058_bib15","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41420-023-01371-8","article-title":"Dihydroartemisinin-induced ferroptosis in acute myeloid leukemia: links to iron metabolism and metallothionein","volume":"9","author":"Grignano","year":"2023","journal-title":"Cell death discovery"},{"key":"10.1016\/j.ejphar.2024.177058_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22168996","article-title":"CAR T-cell therapy in hematological malignancies","volume":"22","author":"Haslauer","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2024.177058_bib17","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.exphem.2023.03.002","article-title":"Human umbilical cord mesenchymal stem cells ameliorate acute graft-versus-host disease by elevating phytosphingosine","volume":"122","author":"Hong","year":"2023","journal-title":"Experimental hematology"},{"key":"10.1016\/j.ejphar.2024.177058_bib18","doi-asserted-by":"crossref","first-page":"444","DOI":"10.21147\/j.issn.1000-9604.2016.04.08","article-title":"A phase I trial of an oral subtype-selective histone deacetylase inhibitor, chidamide, in combination with paclitaxel and carboplatin in patients with advanced non-small cell lung cancer","volume":"28","author":"Hu","year":"2016","journal-title":"Chinese journal of cancer research = Chung-kuo yen cheng yen chiu"},{"key":"10.1016\/j.ejphar.2024.177058_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.433","article-title":"HDAC1 and Klf4 interplay critically regulates human myeloid leukemia cell proliferation","volume":"5","author":"Huang","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejphar.2024.177058_bib20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41408-021-00425-3","article-title":"Acute myeloid leukemia: current progress and future directions","volume":"11","author":"Kantarjian","year":"2021","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.ejphar.2024.177058_bib21","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1158\/0008-5472.CAN-08-4368","article-title":"Characterization of the HDAC1 complex that regulates the sensitivity of cancer cells to oxidative stress","volume":"69","author":"Kato","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2024.177058_bib22","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/bjh.17746","article-title":"Updates on targeted therapies for acute myeloid leukaemia","volume":"196","author":"Kayser","year":"2022","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ejphar.2024.177058_bib23","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40880-018-0288-x","article-title":"Amino acid transporter SLC7A11\/xCT at the crossroads of regulating redox homeostasis and nutrient dependency of cancer","volume":"38","author":"Koppula","year":"2018","journal-title":"Cancer Commun."},{"key":"10.1016\/j.ejphar.2024.177058_bib24","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41375-023-02130-5","article-title":"Targeting ZDHHC21\/FASN axis for the treatment of diffuse large B-cell lymphoma","volume":"38","author":"Liu","year":"2024","journal-title":"Leukemia"},{"key":"10.1016\/j.ejphar.2024.177058_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2023.106398","article-title":"Chidamide, a novel histone deacetylase inhibitor, inhibits laryngeal cancer progression in vitro and in vivo","volume":"158","author":"Liu","year":"2023","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ejphar.2024.177058_bib26","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/jcp.21366","article-title":"The x(c)- cystine\/glutamate antiporter: a potential target for therapy of cancer and other diseases","volume":"215","author":"Lo","year":"2008","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ejphar.2024.177058_bib27","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s13148-023-01531-8","article-title":"Update on histone deacetylase inhibitors in peripheral T-cell lymphoma (PTCL)","volume":"15","author":"Lu","year":"2023","journal-title":"Clin. Epigenet."},{"key":"10.1016\/j.ejphar.2024.177058_bib28","first-page":"886","article-title":"Ferroptosis in acute leukemia","volume":"136","author":"Lyu","year":"2023","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.ejphar.2024.177058_bib29","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/bs.acr.2018.02.006","article-title":"Advances and challenges of HDAC inhibitors in cancer therapeutics","volume":"138","author":"McClure","year":"2018","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.ejphar.2024.177058_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102149","article-title":"HDAC inhibition induces EMT and alterations in cellular iron homeostasis to augment ferroptosis sensitivity in SW13 cells","volume":"47","author":"Oliveira","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.ejphar.2024.177058_bib31","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","article-title":"Genomic classification and prognosis in acute myeloid leukemia","volume":"374","author":"Papaemmanuil","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2024.177058_bib32","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1200\/JCO.2009.23.2652","article-title":"Randomized study of intensified anthracycline doses for induction and recombinant interleukin-2 for maintenance in patients with acute myeloid leukemia age 50 to 70 years: results of the ALFA-9801 study","volume":"28","author":"Pautas","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejphar.2024.177058_bib33","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13045-017-0439-6","article-title":"Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China","volume":"10","author":"Shi","year":"2017","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.ejphar.2024.177058_bib34","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA: a cancer journal for clinicians"},{"key":"10.1016\/j.ejphar.2024.177058_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13679-023-00542-z","article-title":"Obesity and leukemia: biological mechanisms, perspectives, and challenges","volume":"13","author":"Tsilingiris","year":"2024","journal-title":"Current obesity reports"},{"key":"10.1016\/j.ejphar.2024.177058_bib36","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1186\/s13046-019-1397-3","article-title":"Iron and leukemia: new insights for future treatments","volume":"38","author":"Wang","year":"2019","journal-title":"Journal of experimental & clinical cancer research : CR"},{"key":"10.1016\/j.ejphar.2024.177058_bib37","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ymthe.2020.09.024","article-title":"A nuclear long non-coding RNA LINC00618 accelerates ferroptosis in a manner dependent upon apoptosis","volume":"29","author":"Wang","year":"2021","journal-title":"Mol. Ther. : the journal of the American Society of Gene Therapy"},{"key":"10.1016\/j.ejphar.2024.177058_bib38","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.1002\/cam4.5243","article-title":"Drug library screening identifies histone deacetylase inhibition as a novel therapeutic strategy for choriocarcinoma","volume":"12","author":"Watanabe","year":"2023","journal-title":"Cancer Med."},{"key":"10.1016\/j.ejphar.2024.177058_bib39","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41568-021-00355-z","article-title":"Leukaemia: a model metastatic disease","volume":"21","author":"Whiteley","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejphar.2024.177058_bib40","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41392-020-00428-9","article-title":"Ferroptosis: mechanisms and links with diseases","volume":"6","author":"Yan","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.ejphar.2024.177058_bib41","first-page":"E4966","article-title":"Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis","volume":"113","author":"Yang","year":"2016","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.ejphar.2024.177058_bib42","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of ferroptotic cancer cell death by GPX4","volume":"156","author":"Yang","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.ejphar.2024.177058_bib43","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2023.1275774","article-title":"Susceptibility of acute myeloid leukemia cells to ferroptosis and evasion strategies","volume":"10","author":"Zhang","year":"2023","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.ejphar.2024.177058_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106781","article-title":"Virtual screening of novel mTOR inhibitors for the potential treatment of human colorectal cancer","volume":"140","author":"Zhang","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejphar.2024.177058_bib45","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.cell.2023.01.020","article-title":"Human hematopoietic stem cell vulnerability to ferroptosis","volume":"186","author":"Zhao","year":"2023","journal-title":"Cell"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924007489?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299924007489?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,8]],"date-time":"2024-12-08T01:27:58Z","timestamp":1733621278000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299924007489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":45,"alternative-id":["S0014299924007489"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.177058","relation":{},"ISSN":["0014-2999"],"issn-type":[{"type":"print","value":"0014-2999"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low-dose treatment with Epirubicin, a novel histone deacetylase 1 inhibitor, exerts anti-leukemic effects by inducing ferroptosis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2024.177058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"177058"}}